The von Hippel–Lindau protein is a tumor suppressor gene involved in the negative regulation of HIF-1α in normoxic conditions, whereas mutations on the VHL gene or hypoxic conditions prevent HIF-1α degradation, which promotes the expression of angiogenic and inflammatory mediators [16]. This evidence concerns the gene HIF1A and neoplasm.